FDA approves Bristol Myers Squibb's schizophrenia drug - CNBC
WEB18 hours ago — The Food and Drug Administration approved Bristol Myers Squibb’s highly anticipated schizophrenia drug, the first novel type of treatment for the debilitating, chronic mental disorder in more ...
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA …
WEB3 hours ago — Bristol Myers Squibb shares rose Friday, a day after its schizophrenia drug was approved for use by the Food and Drug Administration.
US FDA approves Bristol Myers' schizophrenia drug
WEB18 hours ago — The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the first new type of antipsychotic medicine in decades.
FDA approves Bristol Myers Squibb's new schizophrenia drug
WEB2 hours ago — The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s the first novel treatment for the ...
Bristol Myers Squibb - U.S. Food and Drug Administration …
WEB1 day ago — PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY™ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults. 1 COBENFY represents the first new class of medicine in several decades and introduces ...
U.S. Food and Drug Administration Approves Bristol Myers Squibb…
WEB16 hours ago — U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults
Bristol-Myers wins FDA nod for first-of-its-kind antipsychotic
WEBThe U.S. Food and Drug Administration (FDA) on Thursday approved Cobenfy (xanomeline and trospium chloride), developed by Bristol-Myers Squibb (NYSE:BMY), as a novel treatment for adults with the ...
Bristol-Myers Squibb stock jumps on schizophrenia drug approval
WEB8 hours ago — Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.
Bristol Myers (BMY) Gets US Nod for First New Schizophrenia Drug …
WEB18 hours ago — Bristol Myers Squibb Co. gained US approval for the first new type of schizophrenia drug in seven decades, opening a fresh avenue of treatment for millions with the serious mental disorder.
US FDA approves Bristol Myers' schizophrenia drug - Yahoo
WEB7 hours ago — A sign stands outside a Bristol Myers Squibb facility in Cambridge. (Reuters) -The U.S. FDA approved Bristol Myers Squibb's schizophrenia drug on Thursday, providing patients with a treatment ...
Skip to content